Neurology Letters
Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nazanin Razazian
Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Adrina Habibzadeh; Sara Dehghani; Samin Shiati
Management of seizure in patients with multiple sclerosis (ORP-51)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ali Akbar Asadi-Pooya
The role of stereotactic biopsy in atypical brain lesions (ORP-52)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sohrab Shahzadi
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Saba Naghavi; Fereshteh Ashtari; Aryan Kavosh; Ahmad Pourmohammadi; Iman Adibi; Arshia Ghalamkari; Zahra Karimi
System biology review of multiple sclerosis and discovery of drug targets (ORP-54)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ali Alizadeh Amiri
Spinal cord MRI in multiple sclerosis; diagnostic, prognostic, and clinical value (ORP-55)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Vahid Shaygannejad
Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Poursadeghfard
Optic neuritis updates (ORP-57)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nahid Beladi Moghadam
A middle-aged woman with history of Multiple sclerosis presented with sub-acute encephalopathy (ORP-58)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sanaz Heydari
Reduction in Circulating Vitamin D Binding Protein in Patients with Multiple sclerosis (ORP-59)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zhila Maghbooli
Multiple Sclerosis (MS) and Legal Medical Doctrines (ORP-60)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Reza Hajmanouchehri
MS and Environmental Factors (ORP-61)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mehdi Moghadasi
Care ethics and empathic Practices in dealing with MS Patients (ORP-62)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hanieh Zaer Rezaei
The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ebrahim Kouchaki; Nasim Safa
What should we do to reduce the complications of Deep brain stimulation in Parkinson's disease?
Volume 1, Issue 1, June 2022, Pages 1-11
Fardin Nabizadeh
Review Current and Emerging Treatment Options for Alzheimer's Disease
Volume 2, Issue 1, April 2023, Pages 1-5
Dimple Kumar Vats; Nistara Biswas; Preethi Pandian; Anupam Kamalakannan
Proposing Strategies to Increase Pregnancy-Related Awareness Among Multiple Sclerosis Patients in Iran
Volume 3, Issue 1, January 2024, Pages 1-2
Elnaz Asadollahzadeh; Sam Daneshvar
Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease
Volume 3, Supplementary 1 (Diagnostic and Therapeutic advances in Neurodegenerative diseases), April 2024, Pages 1-6
Marjan Assefi; Alireza Sharafshah; Atefeh Ashtari; Sayeh Afshar; Keysan Pour Moghtader; Yasir Waheed
The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine
Volume 3, Issue 1, January 2024, Pages 3-11
Mohammad Balabandian; Mobin Mohammadi; Arashk Mallahzadeh
Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy
Volume 2, Issue 1, April 2023, Pages 6-12
Sheida Shaafi; Seyede Maryam Nasibi; Gholamreza Chalabianloo; Seyed Aria Nejadghaderi
Biomaterials in The Treatment of Amyotrophic Lateral Sclerosis
Volume 1, Issue 1, June 2022, Pages 12-16
Fardin Nabizadeh
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study
Volume 3, Issue 1, January 2024, Pages 12-19
Behnaz Moradi; Fatemeh Zare Bidoki; Javid Azadbakht; Mahboobeh Shirazi; Hassan Hashemi; Sedigheh Hantooshzadeh; Mohamad Ali Kazemi; Mohammad Shafiee; Mohammad Hossein Golezar
Guillain-Barré syndrome in remission of Ulcerative colitis: a case report
Volume 2, Issue 1, April 2023, Pages 13-15
Maedeh Khodkam; Delaram Panahi
Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease
Volume 2, Issue 1, April 2023, Pages 16-24
Fardin Nabizadeh; Mohammad Balabandian; Mohammad Reza Rostami; Soraya Mehrabi; Mohsen Sedighi
)